XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-controlling Interests
Balances (in Shares) at Dec. 31, 2021   18,861,130        
Balances at Dec. 31, 2021 $ 27,012,445 $ 1,888 $ 122,336,607 $ 113,446 $ (92,937,863) $ (2,501,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options and vesting of restricted stock (in shares)   30,370        
Exercise of stock options and vesting of restricted stock 3 $ 3        
Stock-based compensation 1,455,641   1,455,641      
Currency translation adjustment (13,684)     (13,684)    
Preferred dividends - non-controlling interest (64,015)         (64,015)
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)
Net loss (4,731,261)       (4,630,328) (100,933)
Balances (in Shares) at Mar. 31, 2022   18,891,500        
Balance at Mar. 31, 2022 23,497,663 $ 1,891 123,792,248 99,762 (97,568,191) (2,828,047)
Balances (in Shares) at Dec. 31, 2021   18,861,130        
Balances at Dec. 31, 2021 27,012,445 $ 1,888 122,336,607 113,446 (92,937,863) (2,501,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Currency translation adjustment (39,998)          
Net loss (10,189,362)          
Balances (in Shares) at Jun. 30, 2022   19,709,763        
Balance at Jun. 30, 2022 23,453,923 $ 1,986 129,459,590 73,448 (102,836,347) (3,244,754)
Balances (in Shares) at Dec. 31, 2021   18,861,130        
Balances at Dec. 31, 2021 27,012,445 $ 1,888 122,336,607 113,446 (92,937,863) (2,501,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 36,900,000          
Balances (in Shares) at Dec. 31, 2022   24,272,150        
Balance at Dec. 31, 2022 23,245,400 $ 2,427 144,073,505 76,182 (116,956,528) (3,950,186)
Balances (in Shares) at Mar. 31, 2022   18,891,500        
Balances at Mar. 31, 2022 23,497,663 $ 1,891 123,792,248 99,762 (97,568,191) (2,828,047)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options and vesting of restricted stock (in shares)   360,018        
Exercise of stock options and vesting of restricted stock 173,625 $ 50 173,575      
Stock-based compensation 1,640,055   1,640,055      
Proceeds from Direct Offering, net of offering costs (in Shares)   134,499        
Proceeds from Direct Offering, net of offering costs 1,994,072 $ 13 1,994,059      
Currency translation adjustment (26,314)     (26,314)    
Preferred dividends - non-controlling interest (65,296)         (65,296)
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)
Proceeds from common stock offering, net of offering costs (in shares)   323,746        
Proceeds from common stock offering, net of offering costs 1,859,685 $ 32 1,859,653      
Net loss (5,458,101)       (5,268,156) (189,945)
Balances (in Shares) at Jun. 30, 2022   19,709,763        
Balance at Jun. 30, 2022 23,453,923 $ 1,986 129,459,590 73,448 (102,836,347) (3,244,754)
Balances (in Shares) at Dec. 31, 2022   24,272,150        
Balances at Dec. 31, 2022 23,245,400 $ 2,427 144,073,505 76,182 (116,956,528) (3,950,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options and vesting of restricted stock (in shares)   91,300        
Exercise of stock options and vesting of restricted stock 0 $ 9 (9)      
Stock-based compensation 1,414,183   1,414,183      
Currency translation adjustment 8,934     8,934    
Preferred dividends - non-controlling interest (69,292)         (69,292)
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)
Proceeds from Direct Offering, net of offering costs (in shares)   543,478        
Proceeds from Direct Offering, net of offering costs 470,000 $ 54 469,946      
Proceeds from common stock offering, net of offering costs (in shares)   78,638        
Proceeds from common stock offering, net of offering costs 136,717 $ 8 136,709      
Net loss (7,660,105)       (7,666,393) 6,288
Balances (in Shares) at Mar. 31, 2023   24,985,566        
Balance at Mar. 31, 2023 17,384,371 $ 2,498 146,094,334 85,116 (124,622,921) (4,174,656)
Balances (in Shares) at Dec. 31, 2022   24,272,150        
Balances at Dec. 31, 2022 23,245,400 $ 2,427 144,073,505 76,182 (116,956,528) (3,950,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Currency translation adjustment 10,233          
Net loss (15,644,202)          
Balances (in Shares) at Jun. 30, 2023   31,257,041        
Balance at Jun. 30, 2023 13,151,907 $ 3,126 150,076,184 86,415 (132,615,484) (4,398,334)
Balances (in Shares) at Mar. 31, 2023   24,985,566        
Balances at Mar. 31, 2023 17,384,371 $ 2,498 146,094,334 85,116 (124,622,921) (4,174,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options and vesting of restricted stock (in shares)   624,400        
Exercise of stock options and vesting of restricted stock 391,191 $ 62 391,129      
Stock-based compensation 1,069,188   1,069,188      
Proceeds from Direct Offering, net of offering costs 1,877,192          
Currency translation adjustment 1,299     1,299    
Preferred dividends - non-controlling interest (70,678)         (70,678)
Accretion on redeemable non-controlling interests preferred shares (161,466)         (161,466)
Proceeds from Direct Offering, net of offering costs (in shares)   4,310,711        
Proceeds from Direct Offering, net of offering costs   $ 432 1,876,760      
Proceeds from common stock offering, net of offering costs (in shares)   1,336,364        
Proceeds from common stock offering, net of offering costs 644,907 $ 134 644,773      
Net loss (7,984,097)       (7,992,563) 8,466
Balances (in Shares) at Jun. 30, 2023   31,257,041        
Balance at Jun. 30, 2023 $ 13,151,907 $ 3,126 $ 150,076,184 $ 86,415 $ (132,615,484) $ (4,398,334)